Paclitaxel-coated balloon or primary bare nitinol stent for revascularization of femoropopliteal artery: A meta-analysis of randomized trials versus uncoated balloon and an adjusted indirect comparison

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 4002-4009

  Fusaro, Massimiliano ^b   Cassese, Salvatore ^a   Ndrepepa, Gjin ^b   King, Lamin A ^b   Tada, Tomohisa ^b   Ott, Ilka ^b   Kastrati, Adnan ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

Bare nitinol stent; Femoropopliteal artery; Meta analysis; Paclitaxel coated balloon; Uncoated balloon

Indexed keywords

NITINOL; PACLITAXEL; ALLOY; BIOMATERIAL;

ARTICLE; BARE METAL STENT; DEATH; DEVICE SAFETY; FEMOROPOPLITEAL ARTERY DISEASE; HUMAN; INTERMETHOD COMPARISON; LEG AMPUTATION; LEG REVASCULARIZATION; META ANALYSIS; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY BALLOON; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESTENOSIS; RISK REDUCTION; SYSTEMATIC REVIEW; ATHEROSCLEROSIS; COMPARATIVE STUDY; FEMORAL ARTERY; HEART MUSCLE REVASCULARIZATION; PATHOLOGY; PROCEDURES; STENT; SURGERY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ALLOYS; ANGIOPLASTY, BALLOON, CORONARY; ATHEROSCLEROSIS; COATED MATERIALS, BIOCOMPATIBLE; FEMORAL ARTERY; HUMANS; MYOCARDIAL REVASCULARIZATION; PACLITAXEL; POPLITEAL ARTERY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STENTS; TREATMENT OUTCOME;

EID: 84886286019     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.06.081     Document Type: Article

References (37)

1. T.W. Rooke, A.T. Hirsch, and S. Misra 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 58 2011 2020 2045
2. European Stroke Organisation, M. Tendera, and V. Aboyans ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC) Eur Heart J 32 2011 2851 2906
3. L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, and F.G. Fowkes Inter-society consensus for the management of peripheral arterial disease (TASC II) J Vasc Surg 45 Suppl. S 2007 S5 S67
4. B.P. Mwipatayi, A. Hockings, M. Hofmann, M. Garbowski, and K. Sieunarine Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: a meta-analysis J Vasc Surg 47 2008 461 469
5. C. Kasapis, P.K. Henke, and S.J. Chetcuti Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials Eur Heart J 30 2009 44 55
6. C.P. Twine, J. Coulston, A. Shandall, and A.D. McLain Angioplasty versus stenting for superficial femoral artery lesions Cochrane Database Syst Rev 2 2009 CD006767
7. F. Acin, J. de Haro, S. Bleda, C. Varela, and L. Esparza Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials J Endovasc Ther 19 2012 585 595
8. W.A. Gray, and J.F. Granada Drug-coated balloons for the prevention of vascular restenosis Circulation 121 2010 2672 2680
9. S. Cassese, R.A. Byrne, and I. Ott Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials Circ Cardiovasc Interv 5 2012 582 589
10. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
11. P. Juni, A. Witschi, R. Bloch, and M. Egger The hazards of scoring the quality of clinical trials for meta-analysis JAMA 282 1999 1054 1060
12. J.A. Sterne, M. Egger, and G.D. Smith Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis BMJ 323 2001 101 105
13. R.M. Harbord, M. Egger, and J.A. Sterne A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints Stat Med 25 2006 3443 3457
14. J.L. Peters, A.J. Sutton, D.R. Jones, K.R. Abrams, and L. Rushton Comparison of two methods to detect publication bias in meta-analysis JAMA 295 2006 676 680
15. F. Song, D.G. Altman, A.M. Glenny, and J.J. Deeks Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses BMJ 326 2003 472
16. H.C. Bucher, G.H. Guyatt, L.E. Griffith, and S.D. Walter The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials J Clin Epidemiol 50 1997 683 691
17. D. Moher, A. Liberati, J. Tetzlaff, and D.G. Altman Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Ann Intern Med 151 2009 264 269 [W64]
18. G. Tepe, T. Zeller, and T. Albrecht Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg N Engl J Med 358 2008 689 699
19. M. Werk, S. Langner, and B. Reinkensmeier Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial Circulation 118 2008 1358 1365
20. M. Werk, T. Albrecht, and D.R. Meyer Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial Circ Cardiovasc Interv 5 2012 831 840
21. A. Schmidt, D. Scheinert, and K. Schulte Comparing paclitaxel releasing balloon catheter versus an uncoated balloon catheter in femoropopliteal lesions European Percutaneous Coronary Revascularisation (EuroPCR) congress, 2012 May, Paris 2012 [Oral presentation available at: http://www.pcronline.com/Lectures/ 2012/Six-month-results-of-the-BIOLUX-P-I-first-in-man-study-comparing-a- paclitaxel-releasing-balloon-catheter-versus-an-uncoated-balloon-catheter-in- femoro-popliteal-lesions.]
22. D. Scheinert Lessons learned from LEVANT I first-in-human study: 24-month final analysis Transcatheter cardiovascular therapeutics congress, 2012 October, Miami Beach, FLA 2012 [Oral presentation available at: http://www.tctmd.com/txlist.aspx?tid=1178323&trid=275 ]
23. M. Schillinger, S. Sabeti, and C. Loewe Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery N Engl J Med 354 2006 1879 1888
24. H. Krankenberg, M. Schluter, and H.J. Steinkamp Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST) Circulation 116 2007 285 292
25. P. Dick, H. Wallner, and S. Sabeti Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions Catheter Cardiovasc Interv 74 2009 1090 1095
26. J.R. Laird, B.T. Katzen, and D. Scheinert Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial Circ Cardiovasc Interv 3 2010 267 276
27. N. Chalmers, P.T. Walker, and A.M. Belli Randomized trial of the SMART stent versus balloon angioplasty in long superficial femoral artery lesions: the SUPER study Cardiovasc Intervent Radiol 36 2013 353 361
28. T. Zeller Endovascular treatment of atherosclerotic popliteal artery lesions - balloon angioplasty versus primary stenting: a prospective, multi-centre, randomised study (ETAP) Transcatheter cardiovascular therapeutics congress, 2012 October, Miami Beach, FLA 2012 [Oral presentation available at: http://www.tctmd.com/txshow.aspx?tid=1178287&id=113853&trid=75 ]
29. D.O. Martin, and H. Austin An exact method for meta-analysis of case-control and follow-up studies Epidemiology (Cambridge, Mass.) 11 2000 255 260
30. M. Early, and D.J. Kelly The consequences of the mechanical environment of peripheral arteries for nitinol stenting Med Biol Eng Comput 49 2011 1279 1288
31. R.R. Saxon, J.M. Coffman, J.M. Gooding, E. Natuzzi, and D.J. Ponec Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial J Vasc Interv Radiol 14 2003 303 311
32. M. Joner, G. Nakazawa, and C. Bonsignore Histopathologic evaluation of nitinol self-expanding stents in an animal model of advanced atherosclerotic lesions EuroIntervention 5 2010 737 744
33. H.Q. Zhao, A. Nikanorov, R. Virmani, R. Jones, E. Pacheco, and L.B. Schwartz Late stent expansion and neointimal proliferation of oversized Nitinol stents in peripheral arteries Cardiovasc Intervent Radiol 32 2009 720 726
34. O. Schlager, P. Dick, and S. Sabeti Long-segment SFA stenting - the dark sides: in-stent restenosis, clinical deterioration, and stent fractures J Endovasc Ther 12 2005 676 684
35. M.D. Dake, G.M. Ansel, and M.R. Jaff Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results Circ Cardiovasc Interv 4 2011 495 504
36. F. Song, T. Xiong, and S. Parekh-Bhurke Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study BMJ 343 2011 d4909
37. S. Cassese, R.A. Byrne, T. Tada, L.A. King, and A. Kastrati Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials Eur Heart J 33 2012 3078 3087